Fennec Pharmaceuticals Inc
F:RV41
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fennec Pharmaceuticals Inc
F:RV41
|
US |
|
D
|
Deutsche Bank AG
DUS:DBK
|
DE |
|
M
|
Moody's Corp
DUS:DUT
|
US |
Dividends
Dividend Yield
Fennec Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Fennec Pharmaceuticals Inc
Payout Ratio
Fennec Pharmaceuticals Inc
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for RV41 is .
Peers Comparison
Shareholder Yield
Price Appreciation
RV41 Price
Fennec Pharmaceuticals Inc
| Average Annual Return | 54.41% |
| Standard Deviation of Annual Returns | 110.73% |
| Max Drawdown | -61% |
| Market Capitalization | 236.7m EUR |
| Shares Outstanding | 27 320 000 |
| Percentage of Shares Shorted |
N/A
|
RV41 Return Decomposition
Main factors of price return
Stock Splits
RV41's latest stock split occurred on Sep 5, 2014
The company executed a 1-for-3 stock split, meaning that for every 3 shares held, investors received 1 new share.
Before the split, RV41 traded at 0.52 per share. Afterward, the share price was about 1.633.
The adjusted shares began trading on Sep 5, 2014. This was stock split number 2 in RV41's history, following the previous one in Aug 30, 2011.